We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Diagnostic Test Kit Offers Easy Identification of Virulent Pathogens

By LabMedica International staff writers
Posted on 12 Jan 2017
A technology gap associated with commercially available diagnostic tests in remote and underdeveloped regions prevents timely pathogen identification for effective antibiotic chemotherapies for infected patients.

A portable detection system has been developed that can rapidly identify some of the most virulent, often multi-drug resistant pathogens. More...
This device was designed to be used in places where laboratory resources are lacking, such as isolated villages in developing countries.

An international team of scientists led by those from the University of Wisconsin-Madison developed a new battery powered detection system which is small and simple. Sixteen microchambers each contain a genetic sequence from one of the sixteen pathogens the device is designed to detect. When one of these sequences matches a sequence from a patient sample, a fluorescent light illuminates from within the relevant microchamber.

The investigators picked the sequences the device uses by screening the genomes of the relevant bacteria for unique genetic sequences. Pathogens can be identified using single drops of patient samples from blood, urine, or other bodily fluids. The system can identify Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and various species of the genus, Enterobacter.

To perform Recombinase Polymerase Amplification (RPA) assays in the B-chip, the team added the isothermal RPA mix including species specific primers, fluorescent exoprobe, and buffer to the TwistAmp exo kit lyophilized enzyme pellet using the TwistDX protocol. The investigators used microplate assays to assess the performance of RPA assays for detecting E. faecium, S. aureus, K. pneumoniae, A. baumannii, and P. aeruginosa. This very sensitive assay can provide positive identification with patient samples containing as few as 10 DNA sequences. They designed a portable B-chip detection system for measuring assay fluorescence containing an excitation source, camera, incubation heater, fluorescence filters and software to control the individual components.

The authors concluded that the combination of a simple and portable cartridge-based RPA assays and a versatile electronic reader that can be used to perform assays in the field. Using de-gas driven cartridges provides a unique platform for packaging RPA assays that can simplify their use and potentially reduce contamination by packaging and compartmentalization. The study was published on December 16, 2016, in the journal Applied and Environmental Microbiology.


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.